Available Technologies
# of Displayed Technologies: 2 / 2
Applied Category Filter (Click To Remove): Therapeutics
Medical Food for Cystic Fibrosis
TS-062420 — The Need: Addressing Nutritional Challenges in Cystic Fibrosis
Cystic Fibrosis (CF) presents significant nutritional challenges for individuals living with the condition. Due to the increased energy requirements and difficulties in nutrient absorption, CF patients often struggle to maintain adequat…
- College: College of Education & Human Ecology
- Inventors: DiSilvestro, Robert
- Licensing Officer: Dahlman, Jason "Jay"
Novel peptides for the treatment of type 1 and 2 diabetes and their neurological complications
TS-037747 —
A novel peptide therapeutic AAC2 comprising amino acids with a coumarin-modified side chain that improves glucose control and reduces neurological decline and anxiety through activation of the insulin-insensitive glucose transporter 1 (GLUT1).
A national study done in 2016 on US adults with diabetes estimated that 0.5% of the population was diagnosed with type 1 diabetes (T1D) (~1.6 million) and 8.5% was diagnosed with type 2 diabetes (T2D) (~27 million). Globally there are ~415 million adults living with diabetes in 2015, with a projec…
- College: College of Education & Human Ecology
- Inventors: Ziouzenkova, Ouliana; Parquette, Jonathan
- Licensing Officer: He, Panqing
